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Optimizing community case management 
strategies to achieve equitable reduction 
of childhood pneumonia mortality: An 
application of Equitable Impact Sensitive Tool 
(EQUIST) in five low– and middle–income 
countries
Background The aim of this study was to populate the Equitable 
Impact Sensitive Tool (EQUIST) framework with all necessary data 
and conduct the first implementation of EQUIST in studying cost–
effectiveness of community case management of childhood pneu-
monia in 5 low– and middle–income countries with relation to eq-
uity impact.
Methods Wealth quintile–specific data were gathered or modelled 
for all contributory determinants of the EQUIST framework, name-
ly: under–five mortality rate, cost of intervention, intervention ef-
fectiveness, current coverage of intervention and relative disease 
distribution. These were then combined statistically to calculate the 
final outcome of the EQUIST model for community case manage-
ment of childhood pneumonia: US$ per life saved, in several differ-
ent approaches to scaling–up.
Results The current ‘mainstream’ approach to scaling–up of inter-
ventions is never the most cost–effective. Community–case manage-
ment appears to strongly support an ‘equity–promoting’ approach 
to scaling–up, displaying the highest levels of cost–effectiveness in 
interventions targeted at the poorest quintile of each study country, 
although absolute cost differences vary by context.
Conclusions The relationship between cost–effectiveness and eq-
uity impact is complex, with many determinants to consider. One 
important way to increase intervention cost–effectiveness in poorer 
quintiles is to improve the efficiency and quality of delivery. More 
data are needed in all areas to increase the accuracy of EQUIST–
based estimates.
Three years are left until the 2015 deadline to achieve the Millennium De-
velopment Goals (MDGs) and much progress has been achieved. A recent 
Inter–Agency Group for Child Mortality Estimation (IGME) meeting re-
ported a child mortality decrease of over one third from 1990 to 2010 [1]. 
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We recently described a conceptual framework that helps 
understanding the complex interplay between determi-
nants of cost–effectiveness and equitable impact in child 
mortality reduction (see Figure 1 for visual representation 
of the framework), also exposing the importance of sever-
al critical determinants for which information is typically 
lacking [6]. The tool based on this framework has been 
named EQUIST – EQUitable Impact Sensitive Tool [7]. 
This study presents the first implementation of EQUIST to 
test the hypothesis that, against conventional wisdom and 
prevailing practices, significantly higher gains in child mor-
tality reduction can be achieved through an equity–focused 
approach to scaling–up of child health interventions with-
out compromising cost–effectiveness.
METHODS
To test EQUIST, five exemplar countries representative of 
larger WHO regions were used: Nigeria (Sub–Saharan Af-
rica), Egypt (Eastern Mediterranean), Bangladesh (South–
East Asia), Cambodia (Western Pacific) and Peru (Ameri-
cas) (Figure 2). These were selected because of their large 
size and relatively adequate information reported by eq-
uity strata. It was also decided to focus on a single disease 
– pneumonia, which is still the leading cause of child 
deaths globally [8]. To allow appropriate close scrutiny, a 
single intervention was studied, namely community case 
However, an unforeseen issue is that in many low– and 
middle–income countries (LMICs) a decrease in under–five 
mortality rate (U5MR) has been accompanied by increased 
inequity in health outcomes between the poor and those 
better off [2]. This important consideration has been dis-
cussed extensively in a recent United Nations Children’s 
Fund (UNICEF) report which argues for abandoning the 
‘mainstream approach’ where scaling–up of child health 
interventions is first provided to more readily accessible 
(and typically wealthier) groups in society. Instead, an ‘eq-
uity–focused’ approach is suggested, contending that it is 
more cost–effective to target interventions at the poorest in 
society, resulting in a greater U5MR decrease while also 
positively impacting upon equity.
To test this hypothesis, a tool is required that can address 
the many determinants in the multifaceted relationship be-
tween cost–effectiveness and equitable impact in child 
mortality reduction. Although a number of tools have been 
developed to assist intervention prioritization at local and 
national levels – such as Marginal Budgeting for Bottle-
necks (MBB, supported by UNICEF) [3],Choice of Inter-
ventions that are Cost–Effective (CHOICE, promoted by 
the World Health Organization – WHO) [4], and the Lives 
Saved Tool (LiST, developed by Johns Hopkins University 
and Futures Institute) [5], none of these tools can fully ad-
dress equitable impact considerations as they make no al-
lowance for income–related inequalities in countries.
Figure 1 Conceptual framework for EQUIST [6], demonstrating a hypothetical planning exercise 
assessing the cost–effectiveness of delivery of a new intervention to different equity strata in the 
population (quintile Q2 vs Q3 vs Q4) with a fixed budget.
www.jogh.org • doi: 10.7189/jogh.02.020402 2 December 2012  •  Vol. 2 No. 2  •  020402
V
IE
W
PO
IN
TS
PA
PE
RS
Waters	et	al.	
management with antibiotics (CCM), which has proven ef-
ficacy in reducing child pneumonia mortality [9,10]. The 
Child Health Epidemiology Reference Group (CHERG) es-
timates of worldwide child mortality for 2008 [11] were 
used, as these data are complete, high–quality, and coincide 
closely with the most recent Demographic and Health Sur-
vey (DHS) data in the five chosen countries [12-16].
Estimates of U5MR
The first step in populating this model was to establish 
U5MR distribution by wealth quintiles in the five countries, 
along with the quintile ratio (QR), a commonly used mea-
sure of equity (the closer QR is to 1, the closer the country 
is to health outcomes equity [17]). For all of the countries, 
data were available from DHS reports 2007, 2008 or 2010 
[12-16], therefore correlating strongly with the most recent 
CHERG data.
Cost estimates
The second step was to estimate the cost of scaling–up 
CCM in each quintile from its existing level of coverage. 
For more accurate estimation, cost was split for CCM into 
antibiotic costs and non–antibiotic costs. It was assumed 
that the direct costs of antibiotics (ie, the medicines them-
selves) would be constant across countries and quintiles, 
while the non–antibiotic costs were likely to be different 
due to factors including geography, infrastructure and hu-
man resources [18].
Direct antibiotic costs for CCM were taken as US$ 0.27 for 
all quintiles in all areas [8]. Non–antibiotic costs were mod-
elled based on an unpublished report from Pakistan [19], 
which was the only available source, highlighting the gen-
eral scarcity of information on this important variable. Di-
rect CCM cost was added to non–CCM costs calculated 
from the quintile’s U5MR to obtain an estimate of the cost 
for each intervention per child treated in any individual 
quintile. In the next step, to gain a more 
accurate measure of the cost of treat-
ment per quintile, the cost per child 
treated was multiplied by the total num-
ber of under–five episodes of pneumo-
nia in each quintile. The number of epi-
sodes was estimated by combining a 
modelled case fatality rate (CFR) for 
each quintile with the estimated number 
of under–five pneumonia deaths.
Estimates of current 
intervention coverage
The third step was to determine cover-
age levels of the chosen intervention in 
the five countries in 2008. Coverage 
with CCM was assumed to be the same as the indicator “% 
under–fives with suspected pneumonia receiving antibiot-
ics” used in UNICEF 's “The State of the World’s Children” 
(SOWC) reports.
Effectiveness estimates
The fourth step was to estimate how CCM’s effectiveness var-
ied according to the quintile in which it was implemented 
and therefore calculate the quintile–specific potential impact 
fraction (PIF). Effectiveness was modelled by graphing ef-
fectiveness reported in each study used in a review of CCM 
[9], against the U5MR for the specific country at the year of 
study publication (taken from Child Mortality Estimates da-
tabase [20]). The estimate for each quintile given using the 
equation of this graph was then adjusted upwards by 50% 
of the remaining effectiveness gap as suggested in the meth-
ods used by Theodoratou et al [9] and the LiST [5].
Disease proportion estimates
Finally, it was necessary to populate the model with disease 
burden estimates for each disease in each quintile. This was 
initially attempted through systematic literature review; 
however an attempt (using MEDLINE, EMBASE and Glob-
al Health databases) yielded insufficient data therefore it 
was decided to model them instead. Data on distributions 
of under–five mortality deaths by cause for all countries 
(from the CHERG report [11]) were combined with U5MR 
data for each country (from SOWC 2009 [21]) in a model, 
resulting in estimates of cause–specific mortality in each 
quintile for each global region, and subsequently for the 
exemplar countries.
Final model
Once the model was fully populated with data necessary 
to evaluate cost–effectiveness and impact on mortality and 
equity of community case management for under–five 
Figure 2 Exemplar countries used in the study.
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pneumonia mortality, it was decided to compare the cost 
per number of lives saved for scaling–up the intervention 
in the next wealthiest 10% of the uncovered population 
(‘inequity promoting’ approach [6]), in the middle 10% of 
the uncovered population (‘equity neutral’ [6]), in the 
poorest 10% of the population (‘equity–promoting’ [6]), 
and finally a 10% scale–up in the ‘mainstream approach’ 
(coverage scale–up continuing to follow current quintile–
specific relative distribution [22]).
Further detailed information on the methods described 
above in each section is presented in Online Supplemen-
tary Document (table w1).
RESULTS
Table 1 and Figure 3 show the estimates of U5MR (as 
deaths per 1000 live births) by quintile for the exemplar 
countries. Quintile ratios for each country are shown in 
Figure 4. Data for each country exhibit expected trends of 
U5MR decreasing with wealth [11]; however, not all to 
similar degrees. Nigeria is shown to have a noticeably high-
er U5MR than the other 5 countries and this is supported 
by the 2008 CHERG report, which found the significant 
majority of under–5 mortality to occur in Africa [11]. Peru 
has the greatest QR ratio, suggesting it has the highest in-
equity. Bangladesh exhibits a higher U5MR in each quintile 
than Peru but a much less significant U5MR variation be-
tween quintiles (especially quintile Q3–Q5), and the low-
est QR of the five countries, suggesting it is the most equi-
table studied.
Figure 4 shows estimates of coverage by wealth quintile 
for community case management (CCM). Although the es-
timates of coverage by quintile for community case man-
Table 1 Cost of community case management (CCM) per child treated in each country by wealth quintile (Q)
Overall Q1 (wealthiest) Q2 Q3 Q4 Q5 (poorest)
Nigeria:
U5MR 189.00 87.00 129.00 165.00 212.00 219.00
Cost of antibiotic (US$) 0.27 0.27 0.27 0.27 0.27 0.27
Non–antibiotic cost (US$) 2.52 1.43 1.87 2.26 2.76 2.84
Total cost of CCM per child treated 2.79 1.70 2.14 2.53 3.03 3.11
Egypt:
U5MR 36.00 18.90 27.20 32.20 36.10 49.00
Cost of antibiotic (US$) 0.27 0.27 0.27 0.27 0.27 0.27
Non–antibiotic cost (US$) 0.88 0.70 0.79 0.84 0.88 1.02
Total cost of CCM per child treated 1.15 0.97 1.06 1.11 1.15 1.29
Bangladesh:
U5MR 61.00 43.00 62.00 83.00 85.00 86.00
Cost of antibiotic (US$) 0.27 0.27 0.27 0.27 0.27 0.27
Non–antibiotic cost (US$) 1.15 0.95 1.16 1.38 1.40 1.41
Total cost of CCM per child treated 1.42 1.22 1.43 1.65 1.67 1.68
Cambodia:
U5MR 54.00 30.00 49.00 68.00 83.00 90.00
Cost of antibiotic (US$) 0.27 0.27 0.27 0.27 0.27 0.27
Non–antibiotic cost (US$) 1.07 0.82 1.02 1.22 1.38 1.46
Total cost of CCM per child treated 1.34 1.09 1.29 1.49 1.65 1.73
Peru:
U5MR 27.00 9.00 24.00 24.00 33.00 59.00
Cost of antibiotic (US$) 0.27 0.27 0.27 0.27 0.27 0.27
Non–antibiotic cost (US$) 0.78 0.59 0.75 0.75 0.85 1.13
Total cost of CCM per child treated 1.05 0.86 1.02 1.02 1.12 1.40
U5MR – under–five mortality rate
Figure 3 U5MR and inequity by wealth quintiles in exemplar 
countries.
Figure 4 Community case management (CCM) coverage 
estimates by wealth quintiles in exemplar countries.
www.jogh.org • doi: 10.7189/jogh.02.020402 4 December 2012  •  Vol. 2 No. 2  •  020402
V
IE
W
PO
IN
TS
PA
PE
RS
Waters	et	al.
agement generally follow expected trends of decreasing 
coverage with increasing poverty (the greatest differences 
by quintile being found in Nigeria and Cambodia), Egypt 
exhibits a slightly unexpected pattern with increased CCM 
of suspected pneumonia in Q2 and Q3 as compared with 
Q1. This is thought to be due to the fact that in rich urban 
communities (ie, Q1), medical professionals are trying to 
avoid over–treating (and therefore promoting antibiotic re-
sistance), but in poorer quintiles this is not the case and 
more cases are treated aggressively with antibiotics, ex-
plaining the higher coverage levels. There is then a dip 
again in coverage observed in Q4 and Q5 in Egypt, likely 
to be explained by poor access to health care in the poor-
est part of the population.
Figure 5 illustrates the model for non–antibiotic cost for 
CCM and Table 1 shows the final ‘cost per child treated’ 
calculated for CCM in each quintile of the exemplar coun-
tries. A consistent trend is observed of increasing interven-
tion cost from Q1–Q5 with Cambodia showing the biggest 
cost differences between Q1–Q2 and Q2–Q3 and Nigeria 
between Q3 and Q4. These countries also show the high-
est overall cost difference.
Figure 6 illustrates the case fatality rates modelled for each 
quintile (region–specific graphic models are displayed in 
the Online Supplementary Document, table w2) and Fig-
ure 7 shows the resulting adjusted cost per quintile treated. 
Again the trend almost uniformly shows an increasing cost 
from Q1–Q5, with one noticeable difference – the finding 
of Q5 in Nigeria being marginally less costly than Q4, sug-
gesting that the case fatality in Q5 is so high that scaling–
up in this quintile will save more money than in Q4 for the 
same investment.
Table 2 shows data used to model CCM effectiveness/PIF 
and Figure 8 illustrates the model. Importantly, Table 2 
highlights scarcity in CCM effectiveness data, as although 
these papers were carefully screened in a recent review and 
found to be high–quality [9], none of them were published 
after 1998. Figure 9 illustrates the upwards–adjusted ef-
fectiveness data for each quintile in each country, showing 
a continual trend of decreasing effectiveness from Q1 to Q5 
but with the biggest decrease being seen in Nigeria, where 
the poorer quintiles have a significantly higher U5MR.
Figure 10 shows quintile–specific disease proportion esti-
mates for each of the exemplar countries, expressed as the 
percentage of the total under–five mortality burden. Sig-
nificant differences across wealth quintiles in causes of 
death in those aged under–five can be seen in each of the 
five exemplar countries with all studied countries showing 
increasing proportions of deaths due to malaria, pneumo-
nia and diarrhoea in poorer quintiles while proportions of 
deaths due to congenital abnormalities, preterm birth com-
plications and injury decrease as poverty increases. This is 
Figure 5 Non–antibiotic cost estimate model.
Figure 6 Case fatality rates by wealth quintiles in exemplar 
countries.
Figure 7 Cost of community case management (CCM) treatment 
by wealth quintile in exemplar countries.
Table 2 Data for CCM effectiveness/Potential Impact Fraction 
(PIF) modelling
Study Location Year U5MR Effectiveness
Mtango et al [23] Tanzania 1986 161.40 30.10
Pandey et al [24] Nepal 1989 126.30 84.00
Bang et al [25] India 1990 114.80 49.10
Khan et al [26] Pakistan 1990 123.60 55.00
Reddaiah et al [27] India 1991 111.90 26.00
Pandey et al [28] Nepal 1991 122.00 30.00
Fauveau et al [29] Bangladesh 1992 132.10 50.00
Agarwal et al [30] India 1993 105.60 27.80
WHO [31] Philippines 1998 43.10 35.00
Our suggestion [6] Global 2012 0.00 100.00
U5MR – under–five mortality rate, WHO – World Health Organization
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Figure 8 Effectiveness/Potential Impact Fraction (PIF) model for 
community case management (CCM).
Figure 9 Effectiveness/Potential Impact Fraction (PIF) model for 
community case management (CCM) in each country by wealth 
quintiles in exemplar countries.
thought to be due to the fact that infectious dis-
eases such as malaria and pneumonia are treat-
ed more effectively in richer populations result-
ing in a diminished proportion of deaths due 
to these causes but an increased proportion of 
deaths due to causes that even well–funded 
health systems struggle to deal with such as 
congenital abnormalities or injury.
Bangladesh shows an interesting pattern of 
birth asphyxia, which takes up highest propor-
tion of mortality in Q2 and Q3, potentially sug-
gesting that in these quintiles although the in-
fectious diseases which are prevalent in poorer 
quintiles are still well treated, the health care 
facilities in these quintiles are not as good as in 
Q1 and so more babies die of birth asphyxia.
WHO region–specific disease proportion esti-
mates and models for disease proportion 
against U5MR and quintile–specific numbers 
of deaths in 2008 from each of these causes of 
death in each of the five exemplar countries are 
presented in the Online Supplementary Docu-
ment (tables w3 and w4).
Figure 11 illustrates the final results: cost per 
life saved (in US$) for each quintile in each 
country by scaling–up CCM in the different 
studied strategies.
Strikingly, the ‘mainstream’ approach for CCM 
in all countries is not the most cost–effective, 
instead an equity–promoting approach always 
delivers the greatest cost–effectiveness in terms 
of US$ per life saved. The absolute cost differ-
ences between this and the next most costly ap-
proach differ with context, varying from US$ 
59.92 per life saved in Peru to US$ 1.10 in Ban-
gladesh, where an equity–promoting approach 
is of almost the same cost–effectiveness as an 
equity–neutral approach of scaling up in the 
Figure 10 Modelled cause–specific child mortality by wealth quintiles in 
exemplar countries.
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middle uncovered 10%. It is thought this is due to the dif-
ferences in U5MR from Q3 to Q5 being relatively small in 
Bangladesh, resulting in the differences in disease burden, 
coverage, effectiveness and cost also not being large. This 
can be contrasted with Peru where the greatest difference in 
cost–effectiveness is between equity–promoting and equity–
neutral and the greatest difference in U5MR is between Q5–
Q3. This potentially suggests that in more inequitable con-
texts such as Peru (which has the highest QR of the 
countries studied), an equity–promoting approach will 
have a greater impact when compared with more equitable 
contexts. Egypt is the only modelled country where the 
next most cost–effective scale–up option is the ‘main-
stream’ approach, possibly due to an already relatively eq-
uitable coverage of CCM across quintiles (a difference of 
only 7.6% coverage from Q1 to Q5).
Nigeria is an interesting context to study as due to its ex-
ceedingly high U5MR in poorer quintiles, the effectiveness 
modelled for Q5 is 50.4%. It was thought that this might 
result in an equity–promoting scale–up delivering poor re-
sults however what is observed in actuality is that scale–up 
in Q5 is still the most cost–effective. This highlights that 
the childhood pneumonia burden in this stratum is so great 
that even treating 50% will result in a huge improvement, 
but also that any intervention which could improve effec-
tiveness of CCM could further enhance this and result in 
extremely significant reductions in Nigeria’s overall child-
hood pneumonia burden.
Table 3 shows the exact numbers of lives saved from the 
same investment of US$ 1 000 000 either in the ‘main-
stream’ approach or an equity–promoting approach with 
targeted CCM scaling up in Q5. This is illustrated in Fig-
ure 12. Although it can be seen that an equity–promoting 
approach to investment in CCM always results in a greater 
saving of life than the ‘mainstream’ approach, the gradient 
of the difference varies significantly between countries with 
the greatest contrast found in Peru, the country with the 
highest QR and therefore greatest inequity, again suggest-
ing that an equity–promoting approach is potentially most 
valuable in countries with the highest inequity.
The results for all aspects of this study are further explained 
the Online Supplementary Document (table w1).
DISCUSSION
This study aimed to populate EQUIST [6] with real data 
from five exemplar LMICs and thereby investigate cost–ef-
fectiveness of different strategies to scaling–up childhood 
pneumonia interventions. Apart from noting the scarcity 
of high–quality information in this area, this paper has de-
livered three major outcomes. Firstly, the information gen-
erated through modelling to populate EQUIST represents 
a novel contribution to understanding equity and child 
health in LMICs. Secondly, this paper has shown that EQ-
UIST is potentially a valuable tool for evaluating cost–ef-
fectiveness of different approaches to scaling–up health in-
terventions. Finally, this first implementation of EQUIST 
has highlighted the complexity of relations between the 
multiple determinants of cost–effectiveness and equitable 
impact in LMIC child mortality reduction. Unexpected pat-
terns are seen both in each variable’s distributions and in 
the final outcome results, further compounded by the dif-
ficulty in determining which of the multiple contributory 
variables is influencing the results most. This emphasizes 
that data on equity and cost–effectiveness for intervention 
planning in LMICs can be far from intuitive.
An extensive review of the literature found only one paper 
that attempted to model any child health data split by 
wealth quintile. Amouzou et al used the LiST to model child 
mortality data for richest and poorest quintiles in Bangla-
desh and found this to be within a 95% confidence interval 
of current DHS data [32]. This is an impressive result, sug-
gesting that LiST could play a role in expanding knowledge 
on wealth–related child health outcomes. The paper how-
Table 3 Number of lives saved for US$ 1 million investment 
according to Mainstream vs Equity–promoting model
Country Mainstream model
Equity–
promoting 
(Poorest 10%) 
model
Mainstream vs 
Equity–promoting 
(Poorest 10%) 
model
Nigeria 5108 6037 929
Egypt 5411 6698 1287
Bangladesh 3110 3254 144
Cambodia 7262 8188 925
Peru 5209 7191 1982
Figure 12 Estimated number of lives saved in Mainstream vs Eq-
uity–promoting models for the same investment.
Figure 11 Estimated cost per life saved in exemplar countries.
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ever does not go further to investigate policy implications 
and extensive literature searching found no published at-
tempt to adjust any of the major tools (ie, LiST, MBB or 
CHOICE) for calculating scaling–up costs by wealth quin-
tiles and thereby explore equity considerations. EQUIST 
appears to be the only published framework which ade-
quately addresses these considerations, making it an impor-
tant development for future public health policy.
Limitations
In absence of information, it was necessary to model much 
of the data needed to populate EQUIST including data for 
non–antibiotic costs, as although there are several studies 
estimating overall cost of global scale–up of health systems 
[18,33] and some discussing the cost of more specific 
scale–up of individual countries and/or interventions 
[34,35], no studies were found which reported data on the 
differential cost of scale–up across wealth quintiles al-
though the importance of this difference was highlighted 
by Johns and Torres [18].
Estimates of relative disease proportions split by wealth 
quintile were the most extensive modelling exercise under-
taken and are therefore central to consider when assessing 
this EQUIST implementation’s robustness. The modelling 
was based on data from the highly–cited CHERG report on 
child mortality [11] and the UNICEF SOWC 2009 report 
[36] and is therefore thought to robustly estimate differen-
tial disease proportions. That the model used U5MR in-
stead of GDP to split disease distribution is justifiable as 
the U5MR for Q1–Q5 in each country was known, so this 
could be used as a common denominator to determine 
quintile–specific disease distribution.
Limitations of the data in this study are further explained 
in the Online Supplementary Document (table w1).
Future research/policy implications
The results of this first implementation of EQUIST provide 
important conclusions. Firstly, one of the main findings of 
this study was the lack of good data in this important area. 
The need for extensive future research to fill gaps should 
be emphasized, especially into variables such as effective-
ness and cost of interventions across population wealth 
strata. One potential way of doing this would be to further 
expand the DHS or MICS (Multiple Indicator Cluster Sur-
veys [37]) to collect information on more diverse health 
indicators, including those related to the EQUIST frame-
work variables. This paper also adds to the calls from oth-
ers for future intervention scale–ups to be monitored with 
relation to their differential costs, effectiveness and impacts 
across equity strata so as to widen the knowledge base [38], 
a process which is starting to happen through the UNICEF 
initiative “Monitoring Results for Equity System” (MoRES) 
[39]. The trends observed here for CCM for pneumonia 
may be similar or completely different for other pneumo-
nia interventions or other major causes of childhood mor-
tality and so if further research was conducted to populate 
EQUIST with data for other interventions/diseases, these 
could be investigated and greater understanding could be 
developed regarding equitable impact of childhood mor-
tality interventions more broadly. For example vaccines 
have been shown previously to have a positive impact on 
equity while also reducing childhood mortality significant-
ly, such as in the case of measles vaccination in Bangladesh 
[40]. Therefore, as vaccines against pneumonia such as 
Pneumococcal Conjugate (PC) and Haemophilus influenzae 
(Hib) are rolled out across an increasing number of coun-
tries through the GAVI Alliance [41,42], using EQUIST it 
could be possible to target scale–up in a more informed 
manner, directing vaccines with increased cost–effective-
ness while also promoting equity. Further research/model-
ling however will be necessary to determine the necessary 
components of the EQUIST model for analysing these in-
terventions before any policy recommendations can be 
made.
Another potential facet for future research is the inclusion 
within EQUIST of other indicators of inequity apart from 
wealth. Policy makers are likely to find targeting interven-
tions strictly by wealth quintiles difficult, therefore decom-
posing the components of the EQUIST for other sub–pop-
ulation group measures may be of more use. One potential 
way to do this is to consider using geographical areas to 
split populations as significant variances in U5MR are typ-
ically seen [12-16] and geographical areas are easier for 
policy makers to target. Further research/modelling how-
ever would have to be undertaken to define these groups 
and their values for each component variable of the EQ-
UIST. Another potential discriminatory variable which 
could be explored is gender, as U5MR is known to be high-
er in boys than girls in most LMICs (apart from India and 
China where the opposite is true) [43], however there is 
little known with relation to the other variables of EQUIST 
such as gender differences in disease distribution within 
specific wealth quintiles. If these data were to be attained 
either through survey or modelling, it would be possible 
to apply EQUIST to gender as well as wealth/geography 
and further address equity considerations.
One of the most important findings in this first implemen-
tation of EQUIST is that the current, “mainstream”, ap-
proach never showed the highest cost–effectiveness in 
studied examples. Therefore for CCM scale–up, the current 
approach is unjustifiable. If countries are already not de-
livering interventions maximally cost–effectively, and many 
are increasing inequity, could an equity–focus lead to im-
provement in both areas? The CCM cost–effectiveness data 
generated in this paper suggest that indeed the most cost–
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effective approach is in actuality scale–up in the poorest, 
as although poorer quintiles display a decrease in effective-
ness and an increase in cost of scale–up, the higher burden 
of disease and case fatality observed in these strata is great 
enough to offset this. This potentially lends increased 
weight to policy makers and academics increasingly calling 
for exactly this kind of equity–focus in scale–up of inter-
ventions [2,22,37,43-46]and can be seen as a major devel-
opment in the evidence supporting this call. Although this 
implementation is only the first of EQUIST and therefore 
needs refinement and improvement of data, it is hoped that 
eventually this tool could be used at a national and sub–
national level to aid policy makers to more efficiently target 
intervention scale–up so as to both save a maximal number 
of lives and also impact positively on equity.
This implementation of EQUIST and the conceptual process 
involved behind thinking about intervention scale–up in this 
manner also suggests possible means of further enhancing 
cost–effectiveness, resulting in more lives saved for a given 
investment. The limiting factor in CCM in poorer quintiles 
such as Nigeria seems to be the very low effectiveness of the 
intervention and so it is implied that enhancement of the ef-
ficiency or quality of provision will also significantly decrease 
cost and therefore increase cost–effectiveness [6].This devel-
opment should therefore be a focus for future research so 
that cost concerns do not force resource–limited policy mak-
ers to further perpetuate the observed trends of increasing 
inequity in many countries worldwide [2]. A recent review 
highlights a number of current limiting factors in the effec-
tiveness of community case management including incom-
plete compliance with guidelines, inappropriate choice of 
antibiotics and poor management of treatment failure and 
co–morbidities [47]. These must be overcome if an equitable 
approach to scaling–up CCM is to become practicable in 
some of the world’s poorest countries.
CONCLUSION
Child health information split by wealth strata in LMICs is 
severely lacking. This first implementation of the EQUIST 
framework has expanded knowledge and delivered impor-
tant analyses on cost–effectiveness of different strategies in 
scaling up of community case management to tackle pneu-
monia in five LMICs, demonstrating EQUIST’s potential fu-
ture value. It has highlighted the complexity of interactions 
between equity, cost–effectiveness and their determinants, 
also reinforcing important suggestions for future policy such 
as the significant effect on cost–effectiveness of increasing 
efficiency and quality of interventions in poorer quintiles. 
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